TY - JOUR
T1 - Natural history of renal cortical neoplasms during active surveillance with follow-up longer than 5 years
AU - Haramis, Georgios
AU - Mues, Adam C.
AU - Rosales, Juan Carlos
AU - Okhunov, Zhamshid
AU - Lanzac, Alberto Perez
AU - Badani, Ketan
AU - Gupta, Mantu
AU - Benson, Mitchell C.
AU - McKiernan, James
AU - Landman, Jaime
PY - 2011/4
Y1 - 2011/4
N2 - Objectives: To present our experience with patients who elected active surveillance for renal cortical neoplasms (RCNs) with <5 years of follow-up. Few data are available regarding the long-term natural history of RCNs during surveillance. Methods: We retrospectively reviewed our urologic oncology database and identified 44 patients with 51 RCNs who had received active surveillance for >5 years of follow-up. The patient and tumor characteristics and tumor growth rate and overall survival data were evaluated. Results: The median patient age was 71.7 years (range 55-92), with 32 patients (72.7%) having a Charlson comorbidity index of <2. The median tumor size was 2.67 cm (range 0.9-8.6) at diagnosis. Biopsy was performed in 17 patients (38.6%). Of these 17 patients, clear cell renal cell carcinoma was diagnosed in 15 and papillary renal cell carcinoma in 2 patients. The median follow-up was 77.1 months (range 60-137), and the median growth rate was 0.15 cm/y. Of these patients, 2 (4.5%) required delayed intervention. One underwent laparoscopic radical nephrectomy because of a high tumor growth rate, and one elected to withdraw from active surveillance because of personal anxiety, despite having a stable tumor size for 72 months. The latter patient underwent laparoscopic renal cryoablation. Histopathologic examination revealed clear cell renal cell carcinoma in both cases. No metastases or cancer-related deaths occurred in our cohort; 1 patient died of cardiovascular disease. Conclusions: Most RCNs undergoing surveillance for >5 years grew slowly. The metastatic potential appeared minimal in patients who demonstrated low or absent tumor growth for a long period.
AB - Objectives: To present our experience with patients who elected active surveillance for renal cortical neoplasms (RCNs) with <5 years of follow-up. Few data are available regarding the long-term natural history of RCNs during surveillance. Methods: We retrospectively reviewed our urologic oncology database and identified 44 patients with 51 RCNs who had received active surveillance for >5 years of follow-up. The patient and tumor characteristics and tumor growth rate and overall survival data were evaluated. Results: The median patient age was 71.7 years (range 55-92), with 32 patients (72.7%) having a Charlson comorbidity index of <2. The median tumor size was 2.67 cm (range 0.9-8.6) at diagnosis. Biopsy was performed in 17 patients (38.6%). Of these 17 patients, clear cell renal cell carcinoma was diagnosed in 15 and papillary renal cell carcinoma in 2 patients. The median follow-up was 77.1 months (range 60-137), and the median growth rate was 0.15 cm/y. Of these patients, 2 (4.5%) required delayed intervention. One underwent laparoscopic radical nephrectomy because of a high tumor growth rate, and one elected to withdraw from active surveillance because of personal anxiety, despite having a stable tumor size for 72 months. The latter patient underwent laparoscopic renal cryoablation. Histopathologic examination revealed clear cell renal cell carcinoma in both cases. No metastases or cancer-related deaths occurred in our cohort; 1 patient died of cardiovascular disease. Conclusions: Most RCNs undergoing surveillance for >5 years grew slowly. The metastatic potential appeared minimal in patients who demonstrated low or absent tumor growth for a long period.
UR - http://www.scopus.com/inward/record.url?scp=79953868335&partnerID=8YFLogxK
U2 - 10.1016/j.urology.2010.09.031
DO - 10.1016/j.urology.2010.09.031
M3 - Article
C2 - 21167561
AN - SCOPUS:79953868335
SN - 0090-4295
VL - 77
SP - 787
EP - 791
JO - Urology
JF - Urology
IS - 4
ER -